In colorectal cancer [42] and acute myeloid leukemia [43], miR-9 targets and represses C-X-C Motif Chemokine Receptor 4 (CXCR4), which influences cell proliferation and the epithelial–mesenchymal transition (EMT). This evidence concerns the gene CXCR4 and acute myeloid leukemia.